96 related articles for article (PubMed ID: 8672855)
1. [Expression of the MDR1 gene in five human cell lines of medullary thyroid cancer and reversion of the resistance to doxorubicine by ciclosporin A and verapamil].
Massart C; Gibassier J; Lucas C; Pourquier P; Robert J
Bull Cancer; 1996 Jan; 83(1):39-45. PubMed ID: 8672855
[TBL] [Abstract][Full Text] [Related]
2. [Modulation of cisplatin cytotoxicity by amphotericin B in six human cell lines of medullary thyroid cancer].
Massart C; Gibassier J; Le Gall F; Raoul ML; Leclech G; Lucas C
Bull Cancer; 1996 Aug; 83(8):619-25. PubMed ID: 8869041
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin A, verapamil and S9788 reverse doxorubicin resistance in a human medullary thyroid carcinoma cell line.
Massart C; Gibassier J; Raoul M; Pourquier P; Leclech G; Robert J; Lucas C
Anticancer Drugs; 1995 Feb; 6(1):135-46. PubMed ID: 7756676
[TBL] [Abstract][Full Text] [Related]
4. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
Muller C; Goubin F; Ferrandis E; Cornil-Scharwtz I; Bailly JD; Bordier C; Bénard J; Sikic BI; Laurent G
Mol Pharmacol; 1995 Jan; 47(1):51-6. PubMed ID: 7838133
[TBL] [Abstract][Full Text] [Related]
5. [The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma].
Zhu L; Lang J; Shen K
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):462-6. PubMed ID: 9639738
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic drug resistance in a human medullary thyroid carcinoma cell line: association with overexpression of mdrl gene and low proliferation fraction.
Yang KP; Liang YF; Samaan NA
Anticancer Res; 1991; 11(3):1065-8. PubMed ID: 1888139
[TBL] [Abstract][Full Text] [Related]
8. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
9. Effect of PSC 833 on the efficacy of doxorubicin in vitro in a medullary thyroid carcinoma cell line.
Massart C; Gibassier J; Denais A; Genetet N
Anticancer Res; 1998; 18(4C):2953-6. PubMed ID: 9713490
[TBL] [Abstract][Full Text] [Related]
10. Reversal effects of droloxifene on multidrug resistance in adriamycin-resistant K562 cell line.
Li J; Xu LZ; Yao JJ; Guo WJ; Xia P; Chen Y
Acta Pharmacol Sin; 2001 Nov; 22(11):1023-7. PubMed ID: 11749795
[TBL] [Abstract][Full Text] [Related]
11. Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers.
Abbaszadegan MR; Cress AE; Futscher BW; Bellamy WT; Dalton WS
Cancer Res; 1996 Dec; 56(23):5435-42. PubMed ID: 8968098
[TBL] [Abstract][Full Text] [Related]
12. Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer.
Campling BG; Young LC; Baer KA; Lam YM; Deeley RG; Cole SP; Gerlach JH
Clin Cancer Res; 1997 Jan; 3(1):115-22. PubMed ID: 9815546
[TBL] [Abstract][Full Text] [Related]
13. Molecular cytogenetic characterization of doxorubicin-resistant neuroblastoma cell lines: evidence that acquired multidrug resistance results from a unique large amplification of the 7q21 region.
Flahaut M; Mühlethaler-Mottet A; Martinet D; Fattet S; Bourloud KB; Auderset K; Meier R; Schmutz NB; Delattre O; Joseph JM; Gross N
Genes Chromosomes Cancer; 2006 May; 45(5):495-508. PubMed ID: 16450357
[TBL] [Abstract][Full Text] [Related]
14. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism.
Zatelli MC; Luchin A; Piccin D; Tagliati F; Bottoni A; Vignali C; Bondanelli M; degli Uberti EC
J Clin Endocrinol Metab; 2005 Oct; 90(10):5754-60. PubMed ID: 16091477
[TBL] [Abstract][Full Text] [Related]
16. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
Iwasaki I; Sugiyama H; Kanazawa S; Hemmi H
Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
[TBL] [Abstract][Full Text] [Related]
17. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
18. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
Ramachandran C; Wellham LL
Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
[TBL] [Abstract][Full Text] [Related]
19. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
20. Combined use of tamoxifen, cyclosporin A, and verapamil for modulating multidrug resistance in human hepatocellular carcinoma cell lines.
Kim JH; Chung JB; Park IS; Kim BS; Yoo NC; Choi JH; Roh JK; Kim HS; Kwon OH; Lee KS
Yonsei Med J; 1993 Mar; 34(1):35-44. PubMed ID: 8397460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]